Halaven 0.5
Drug Category |
|
Medicinal form |
Vials |
Active ingredient |
|
Concentration |
0.5mg |
Manufacturer |
|
Price |
3375 EGP |
Uses
Eribulin is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug. This medication is classified as a "non-taxane microtubule inhibitor" treat patients with metastatic breast cancer who have received at least two prior chemotherapy regimens for late-stage disease, including both anthracycline- and taxane - Eribulin is also for use in a variety of other solid tumors, including non-small cell lun cancer, prostate cancer and sarcoma.
Note: The information provided about this drug does not substitute for consulting a doctor.
Direct Access to Pharmacy Through Innovative Portal
Empower your health journey with Direct Access to Pharmacy Through Innovative Portal - Your gateway to seamless and efficient healthcare solutions at your fingertips
See list pharmacies